A higher-order entity formed by the flexible assembly of RAP1 with TRF2 by Gaullier, Guillaume et al.
A higher-order entity formed by the flexible assembly of
RAP1 with TRF2
Guillaume Gaullier, Simona Miron, Sabrina Pisano, Re´mi Buisson, Yann-Va¨ı
Le Bihan, Carine Tellier-Lebe`gue, Wala Messaoud, Pierre Roblin, Beatriz G.
Guimara˜es, Robert Thai, et al.
To cite this version:
Guillaume Gaullier, Simona Miron, Sabrina Pisano, Re´mi Buisson, Yann-Va¨ı Le Bihan, et
al.. A higher-order entity formed by the flexible assembly of RAP1 with TRF2. Nucleic
Acids Research, Oxford University Press (OUP): Policy C - Option B, 2016, 44 (4), pp.1962-
1976. <http://nar.oxfordjournals.org/content/44/4/1962>. <10.1093/nar/gkv1531>. <hal-
01346908>
HAL Id: hal-01346908
https://hal.archives-ouvertes.fr/hal-01346908
Submitted on 19 Jul 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License
1962–1976 Nucleic Acids Research, 2016, Vol. 44, No. 4 Published online 8 January 2016
doi: 10.1093/nar/gkv1531
A higher-order entity formed by the flexible assembly
of RAP1 with TRF2
Guillaume Gaullier1,†, Simona Miron1,†, Sabrina Pisano2, Re´mi Buisson2,
Yann-Vaı¨ Le Bihan1, Carine Tellier-Lebe`gue1, Wala Messaoud1, Pierre Roblin3,4, Beatriz
G. Guimara˜es3, Robert Thai5, Marie-Jose`phe Giraud-Panis2, Eric Gilson2,6 and
Marie-He´le`ne Le Du1,*
1Department of Biochemistry, Biophysics and Structural Biology, Institute for Integrative Biology of the Cell (I2BC),
CEA, UMR 9198 CNRS, Universite´ Paris-Sud, Batiment 144, CEA Saclay, Gif-sur-Yvette, F-91191, France, 2Institute
for Research on Cancer and Aging, Nice (IRCAN); CNRS UMR7284/INSERM U1081; Faculty of Medicine; Nice,
06107, France, 3Synchrotron SOLEIL, L’Orme des Merisiers, Saint-Aubin BP 48, 91192 GIF-SUR-YVETTE Cedex,
France, 4Institut National de la Recherche Agronomique, Unite´ Biopolyme`res, Interactions, Assemblages, 44316
Nantes, France, 5CEA, iBiTecS, F-91191 Gif-sur-Yvette, France and 6Department of Genetics, CHU; Nice, 06107,
France
Received November 10, 2015; Revised December 17, 2015; Accepted December 21, 2015
ABSTRACT
Telomere integrity is essential to maintain genome
stability, and telomeric dysfunctions are associated
with cancer and aging pathologies. In human, the
shelterin complex binds TTAGGG DNA repeats and
provides capping to chromosome ends. Within shel-
terin, RAP1 is recruited through its interaction with
TRF2, and TRF2 is required for telomere protection
through a network of nucleic acid and protein inter-
actions. RAP1 is one of the most conserved shelterin
proteins although one unresolved question is how its
interaction may influence TRF2 properties and regu-
late its capacity to bind multiple proteins. Through a
combination of biochemical, biophysical and struc-
tural approaches, we unveiled a unique mode of as-
sembly between RAP1 and TRF2. The complete in-
teraction scheme between the full-length proteins in-
volves a complex biphasic interaction of RAP1 that
directly affects the binding properties of the assem-
bly. These results reveal how a non-DNA binding pro-
tein can influence the properties of a DNA-binding
partner by mutual conformational adjustments.
INTRODUCTION
Telomeres are specific nucleoprotein complexes that pro-
tect the chromosomes termini against degradation, check-
point activation and illicit repair. Shelterin is a six-protein
complex that constitutes the core of the telomere struc-
ture by binding double-stranded DNA through TRF1
and TRF2 (Telomeric Repeat-binding Factors 1 and 2)
and single-stranded DNA through POT1. TIN2 bridges
TRF1 and TRF2, whereas TPP1 links double-stranded
DNA and single-stranded DNA through its interaction
with POT1 and TIN2, and RAP1 tightly interacts with
TRF2 (1,2). Shelterin functions depend on the recruit-
ment of many associated factors (2,3), and on the for-
mation of specific assemblies with DNA (4). Systematic
study of the telomeric proteins interaction network reveals
more than 1000 protein–protein interactions and telomere-
associated proteins (5). The individual implication of these
proteins in shelterin functions has been extensively studied,
but the functional synergies upon complex formation re-
main poorly understood. Telomere repeats induce subnu-
clear compartments significantly enriched in shelterin pro-
teins. The local high concentration of shelterin proteins
implies that the description of high affinity interactions is
not sufficient to properly understand the regulatory pro-
cesses involved in telomere maintenance. It is known that
weak-affinity (KD > 10−4 M) and transient interactions
are equally important than high-affinity interactions (KD
< 10−6 M) in the regulation of many cellular pathways (6).
However, our understanding of these regulatory processes is
limited by our ability to study short-lived interactions.Weak
and transient interactions are particularly difficult to study
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in multifunctional proteins, which interact with numerous
partners often through a common or similar interface.
Among shelterin proteins, TRF2 is amultifunctional pro-
tein that prevents non-homologous end joining (NHEJ)
and ATM(ataxia telangiectasia mutated)-dependent check-
point as well as DNA replication (2,3,7–9). Moreover,
TRF2 binds several extra-telomeric sites where it regulates
gene expression (10,11). TRF2 is composed of a TRFH
domain involved in homodimer assembly, in recruitment
of several proteins (12–18), in DNA condensation (19,
Benarroch-Popivker et al., in press) and in ATM inhibi-
tion signaling (20), and a C-terminal Myb/telobox domain
that specifically binds double-stranded DNA (21,22). The
basic N-terminal region of TRF2 hosts binding sites for
several telomere-interacting molecules including the telom-
eric RNA TERRA, provides a specific ability to bind Hol-
liday junctions (HJ) and to protect them from resolvase
cleavage, and helps TRF2 to condense DNA and chro-
matin (19,23–27). The long linker between the TRFH
and the Myb/telobox domain contains the binding sites
for the two shelterin proteins RAP1 (Repressor Activa-
tor Protein 1) and TIN2 (28,29), and prevents 53BP1 re-
cruitment to telomeres (20). TRF2/RAP1 complex is in-
volved in NHEJ protection in an in vitro assay (30). Pre-
vious studies have reported that RAP1 deletion does not
seem to affect cell viability or telomere protection in vivo
in a wild-type background (31,32). However, the use of
a separation-of-function mutant of TRF2 revealed that
RAP1 is involved in a backup mechanism that prevents
NHEJ when DNA condensation-mediated telomere pro-
tection is impaired (Benarroch-Popivker et al., in press).
Moreover, ChIP-seq analyses have shown that RAP1 can
be found at chromatin sites in the absence of TRF2 (33,34).
Cytoplasmic localization of RAP1 has also been reported,
as well as its involvement in NF-B signalling (35,36).
A recent study shows that RAP1 can affect TRF2 inter-
action properties toward duplex DNA (37). In TeloPIN
database (5), RAP1 and TRF2 interact respectively with
131 and 247 partners, among which 32 are common part-
ners betweenRAP1, TRF2 and other shelterin proteins and
12 are common partners exclusively between RAP1 and
TRF2. Therefore, whether or not RAP1/TRF2 interaction
may affect/reinforce their respective properties and how
DNA/TRF2 complex recruits its numerous protein part-
ners compared to RAP1/TRF2/DNA complex remain to
be fully characterized.
In order to address this central question, we initi-
ated a comprehensive study of the parameters that de-
scribe the assembly of RAP1 and TRF2. We analysed the
RAP1/TRF2complex both in terms of structure and bind-
ing properties.We observed thatRAP1 affects TRF2 behav-
ior in vitro toward particular DNA structures. Through a
combination of SAXS, ITC, crystallography and biochem-
ical approaches, we were able to delineate the complete in-
teraction scheme between the full-length proteins. Finally,
we confirmed that a construct of RAP1 deleted for its C-
terminal high-affinity binding site is sufficient to modu-
late TRF2 properties toward Holliday junction and ob-
served that the binding properties of TRF2/DNA or of
RAP1/TRF2/DNA toward proteins from HeLa cells nu-
clear extracts are different.
MATERIALS AND METHODS
Protein constructs and peptides used in this study
All protein constructs used in this study are listed in Sup-
plementary Table S1. All peptides are also listed in Supple-
mentary Data.
HJ protection
A total of 5 nMof telomericHJ (tHJ) labelled on one strand
was incubated with different concentrations of proteins in
10 l of binding buffer containing 10 mM MgAc2 and di-
gested for 60 min using 2 nM of T7 Endonuclease I, MBP-
CceI and MBP-RusA or 50 nM of GEN11–527. Reactions
were performed at 4◦C for Endo I or 37◦C for MBP-CceI,
MBP-RusA and GEN11–527. The reaction was stopped by
addition of 6 g of proteinase K followed by 20 min incu-
bation at 4◦C or 15 min at 37◦C. Formamide was added to
a final concentration of 60% (v/v) and the samples loaded
on a 10% denaturing acrylamide (19:1, bis:mono) 1× TBE
gel. After migration in 1× TBE, gels were analysed using a
Phosphorimager TyphoonFLA9000 (GE Healthcare) and
the Image Quant software (GE Healthcare).
EMSA
Proteins were incubated 15 min a 4◦C with 5 nM DNA in
10 l of 20 mMTris-Acetate pH8, 0.1 mg ml−1 BSA, 1 mM
DTT, 50 mM KAc, 30 mM NaCl, 5% (v/v) glycerol (bind-
ing buffer). Gel electrophoresis was performed as published
(38) and gels were analysed as above.
AFM
A total of 50 nM of TRF2 dimer and either 100 nM of full
length Rap1 or Rap1-RCTwere pre-incubated at 0◦C for 15
min in the binding buffer (150 mMKCl, 5 mMHEPES pH
7.4). DNA (final concentration 10 nM) was then incubated
with a 1:1 molar ratio of TRF2 with the preincubated pro-
teins for 20 min at 25◦C in the same binding buffer. Samples
were crosslinked with glutaraldehyde (0.1% final) for 30min
on ice and applied on freshly cleaved mica surfaces treated
with 10 mM MgCl2. After 2 min, mica was washed with 1
ml of deionized water and dried with a gentle flux of nitro-
gen. Imaging was performed on aNanoscope IIIa equipped
with E-scanner (Digital Instruments Inc, Santa Barbara,
CA, USA), in air under Tapping Mode using silicon tips.
Images were recorded at 1.5–2.0 Hz over scan areas 1 m
wide (512× 512 pixels). Raw scanning forcemicroscopy im-
ages were flattened using the manufacturer’s software and
converted into TIF files. Contour lengths (CLs) were mea-
sured by the read-through length method using SigmaScan
Pro software (SPSS Inc, Chicago, IL,USA). Volumes calcu-
lated as half-ellipsoids as published (38). Between 150 and
250 objects were scored for each condition. The 2D prob-
ability density map is a smoothed distribution that repre-
sents the convolution of the experimental distribution with
a s1 × s2 gaussian pulse. To construct the 2D map, each
protein/DNA complex with a raw DNA length Lraw and a
complex volume Volcomplex contributes as gaussian distribu-
tion of respectively s1 and s2 width in Lraw and Volcomplex di-
rections. Each pixel of the 2Dmap is the sum of the various
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gaussian contributions from the experimental data points.
The resulting 2Dmap represents a 100 by 100 pixel image of
the probability to find a protein/DNA complex with given
raw DNA length and complex volume, the intensity of each
pixel is given by the associated probability density colour
scale.
Protein expression and purification
Protocols are detailed in supplementary Data.
SAXS
SAXS experiments were performed at SWING beamline,
synchrotron SOLEIL. TRF2, RAP1 and RAP1-RCT were
set in the buffer containing 20 mM Tris pH = 7.5, 150
mM NaCl, 5 mM 2-mercaptoethanol and 0.2 mM PMSF.
TRF2 was concentrated to 215 M (monomers), RAP1
to 326.7 M, RAP1-RCT to 1015.7M, TRF2 and RAP1
were mixed to 120 and 144M respectively, and TRF2 and
RAP1-RCTweremixed to 171.5 and 205.8Mrespectively,
both corresponding to a RAP1/TRF2 molar ratio of 1.2.
All data were collected at SWING beamline at SOLEIL
synchrotron using either the sample changer (RAP1 full-
length), or using the online HPLC system (39), equipped
with a BIO-SEC3 column (Agilent) for all other proteins
or complexes. After data collection, all leftovers from these
preparations were analysed by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) to ensure
no degradation occurred during the experiments. The de-
tailed analysis of the data is described in supplementary
Data.
Crystallization and structure determination
Crystals of TRFH in complex with peptide RAP1-YLP
89ENRERLELEAYRLGPASA106 were obtained by hang-
ing drop vapour diffusion at room temperature, with a con-
centration of TRFH of 34 mg/ml and a molar ratio of
TRFH/Rap1-YLP of 1:3.5 in a buffer containing 12.5 mM
Tris pH 8.0, 100mMNaCl andDTT2.5mM.Themost suit-
able crystals grew in 16% PEGmme 550, 50 mM Hepes pH
8.0, 5 mMMgCl2, 5 mMDTT. Native diffraction data were
collected on PX1 beamline at SOLEIL synchrotron, and re-
duced with XDS (40). The structure was solved by molec-
ular replacement with PHASER (41), using one TRFH
monomer from 3BUA PDB entry: as model probe (15), and
refined with BUSTER5 (42).
Protein footprinting and Mass spectrometry analysis
The setup of protein footprinting protocols and mass spec-
trometry analysis are detailed in Supplementary Data.
ITC
Molecular interactions (see Supplementary Table S2) were
investigated by Isothermal Titration Calorimetry using a
VP-ITC and an iTC200 instruments (GE Healthcare). The
solutions were degassed prior to use, at the same temper-
ature as those used in the experiments. Integration of the
peaks corresponding to each injection, correction for the
baseline, and the fit were done using Origin-based soft-
ware provided by the manufacturer and enabled to calcu-
late the equilibrium dissociation constants of the interac-
tions presented in this study. The experimental conditions
of all ITC experiments are indicated in Supplementary Ta-
ble S2. Blank experiments (heats of dilution from titrants
into buffer) were also performed.
SEC-MALS
TRF2 protein at a concentration of 100 M (in a buffer
containing 50 mM Tris, pH 7.5, 150 mM NaCl, 10
mM 2-mercaptoethanol) was applied to Bio SEC-3 col-
umn (Agilent) on a HPLC Shimadzu system coupled
to MALS/QELS/UV/RI (Wyatt Technology). Data were
analysed using ASTRA software after calibration with a
bovine serum albumin standard.
Cell culture
HeLa cells were kindly provided by Dr Carl Mann (I2BC),
and grown in 15-cm dishes in DMEM medium supple-
mented with 10% v/v fetal bovine serum and a mix of peni-
cillin and streptomycin to prevent bacterial contamination.
Cells were amplified to 30 15-cm dishes at 80–90% conflu-
ence, and finally harvested by scraping in cold PBS just prior
to the preparation of nuclear extracts.
Preparation of nuclear extracts
Nuclear extracts were prepared following the protocol de-
scribed in (43), with minor modifications detailed in Sup-
plementary Data.
Streptavidin-DNA pull down experiments
The following oligonucleotides were annealed to make a
biotinylated duplex DNA molecule displaying a TRF2
binding site (two tandem TAGGG motifs): biotin-5′-
TACTAGGGTTAGGGTTAGCA-3′ and complementary
5′-ATGCTAACCCTAACCCTAGT-3′ yielding a single
base 5′-overhang at each end. A total of 9 nmoles of biotiny-
lated DNAwere loaded at 0.1 ml/min on a HiTrap Strepta-
vidin HP 1 ml column (GE Healthcare) first equilibrated in
binding buffer (Tris–HCl 20 mM pH 7.5; NaCl 150 mM; 2-
mercaptoethanol 5mM;EDTA0.2mM;PMSF0.1mM).A
peak in A260 indicated that the column was loaded with a
saturating amount of biotinylated DNA. The column was
then loaded at 0.2 ml/min with either TRF2, preformed
TRF2/RAP1 complex, preformed TRF2/RAP1-ARAGA
complex, or nothing (control experiment) and washed with
binding buffer until A280 returned to a flat baseline. In each
case, non-zero A280 of the flow through indicated that the
column was loaded with a saturating amount of protein.
A total of 490 g of nuclear extracts were loaded at 0.2
ml/min on the column. When A280 returned to a flat base-
line, bound proteins were eluted at 0.5 mL/min with elu-
tion buffer (same as binding buffer except NaCl 1 M). Be-
tween each experiment, the column was washed with elu-
tion buffer until A280 returned to a flat baseline, and equi-
librated again in binding buffer. Eluted samples were anal-
ysed by SDS-PAGE.
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Model building and conservation analysis
The BRCT domain of RAP1 was modelled using MOD-
ELLER software (44) and the structure of the BRCT do-
main of Rap1 from S. cerevisiae (45, PDB entry 2L42).
The resulting model and Myb domain of RAP1 (46) were
then manually positioned along the TRFH domain of
TRF2 with Pymol (47, http://www.pymol.org) based on
the TRFH/RAP1-peptide crystal structure and the protein
footprinting results. Conservation analysis was performed
with CONSURF software (48) using 14 sequences for both
TRF2 and RAP1 from the same species of vertebrates (See
sequence codes in Supplementary Data).
RESULTS
RAP1 affects TRF2 binding properties toward DNA
As RAP1 is a key partner of TRF2 probably implicated
in TRF2 multi-functionality, we first measured its effect
on TRF2 ability to interact with various DNA structures.
In addition to linear double stranded TTAGGG (T2AG3)
DNA, TRF2 recognizes branched DNA structures like
HJ, the four-stranded DNA intermediates of homologous
recombination (24,25). Interestingly and in contrast with
what was previously observed (49), ITC (Isothermal Titra-
tion Calorimetry) and EMSA (Electrophoretic Mobility
Shift Assay) experiments show that RAP1 does not bind
linear double stranded TTAGGG (T2AG3) DNA, and does
not prevent TRF2/DNA or TRF2/HJ binding (Supple-
mentary Figure S1). Among different possibilities, one dif-
ference with the RAP1 construct used by Griffith et al.
(49) is the removal of the positively charged His-tag in our
conditions, which presence could lead to unspecific interac-
tion with the negatively charged DNA. Binding of TRF2
to HJ has been shown to protect this structure against the
cleavage of various archetypical resolvases: human GEN1,
T7 Endonuclease I, yeast mitochondrial CCEI and the Es-
cherichia coli RusA enzyme. Interestingly, we observe that
RAP1 inhibits TRF2 protection against these enzymes in a
concentration dependent manner (Figure 1A, Supplemen-
tary Figure S2). This is not due to a removal of TRF2
from the HJ (Supplementary Figure S1F) and we do not
observe a direct effect of RAP1 on the resolvases (Figure
1A, Supplementary Figures S2 and S3), nor an increase
in cleavage when we used the protection-deficient mutant
of TRF2, TRF2B, deleted for the N-terminus B-domain
(Supplementary Figure S3) (25). These results suggest that
this ‘recovery’ of resolvase activity is not caused by aRAP1-
dependent increase in the enzyme activity but rather by
a decrease in TRF2-dependent protection. This effect of
RAP1 was not expected since TRF2 HJ protection origi-
nates from the binding of the N-terminal basic domain of
TRF2 on the centre of the HJ (25), and the known RAP1
Binding Motif (TRF2-RBM) is located at residue 275–316
(28). Intriguingly, when we use a TRF2 mutant lacking the
whole linker (or hinge) domain and thus the TRF2-RBM
(TRF2L, Figure 1B), we still observe this RAP1 effect of
‘anti-protection’ for CCE1 and RusA, although higher con-
centration of RAP1 would be needed (Figure 1C). There-
fore, we conclude that, in our conditions, RAP1 does not
directly interact with DNA as linear double stranded form,
Table 1. X-ray diffraction data collection and refinement statistics
Wavelength (A˚) 0.98
Space-group P21
Diffraction limits (last shell) 2.44 A˚ (2.63 A˚–2.44 A˚)
Unit cells (axbxcxxx ) 53.8 × 104.8 × 85.3
90 × 94.4 × 90
Rmerge 0.068 (0.664)
Number of unique reflections 33 979 (5718)
I/ 1429 (2.26)
Completeness 0.965 (0.794)
Wilson B-factor (A˚2) 51.6
Molecular Replacement (LLG) 1391
Refinement
Resolution 2.44 A˚
Rwork 0.193
Rfree 0.237
Number of non-solvent atoms 6938
Number of water molecules 94
Figure of merit 0.7813
RMSD bond lengths 0.004
RMSD bond angles 0.976
RMSD chirality 15.25
PDB entry 4RQI
LLG: log of likelihood gain.
does not interact with DNA as HJ and does not modify the
capacity of TRF2 to interact with linear or branched DNA.
But interestingly, the presence of RAP1 prevents TRF2 pro-
tection ofHJ independently of the presence of TRF2-RBM.
Table 1.
In addition to its ability to bind particular DNA struc-
tures, TRF2 has been shown to condense linear DNA by
promoting positive supercoils in the bound DNA (19,38,
Benarroch-Popivker et al., in press). As previously de-
scribed (19), we drew 2D-probability maps giving the prob-
ability of any TRF2/DNA complex to exhibit a given vol-
ume in nm3 for a given contour length in nm as measured
by Atomic Force Microscopy (AFM). As previously ob-
served (19), TRF2 shortens DNA and drives the forma-
tion of complexes that become more and more condensed
when the ratio of TRF2 versus DNA increases (Figure 1D,
top). In the presence of a small excess of full-length RAP1,
DNA is still condensed in the complex compared to un-
bound DNA, but the highly condensed complexes largely
disappear (Figure 1D, middle). Interestingly, the use of the
known RAP1 C-terminal TRF2 high-affinity binding do-
main (RAP1-RCT) instead of full-length RAP1 leads to
an increased condensation of DNA (Figure 1D, bottom).
Therefore, RAP1 does not prevent TRF2 to condense lin-
ear DNA, but alters the level of condensation by blocking
high degrees of oligomerization in the TRF2/DNA com-
plexes. But interestingly, RAP1-RCT domain, which tightly
binds TRF2, is not sufficient to block this oligomerization.
Altogether, these data show that RAP1 does not pre-
vent TRF2 interaction with linear or branched DNA, but it
clearly alters some of the properties of TRF2 toward DNA,
in particular by relieving the protective action of TRF2 on
HJ cleavage by resolvase enzymes. Strikingly, this effect of
RAP1 is maintained despite the deletion of the high affin-
ity RAP1-RCT binding-site of TRF2. In the same way, the
isolated RAP1-RCT domain, which contains the high affin-
ity TRF2 binding-site, is not sufficient to prevent TRF2 to
form highly condensed complexes with linear DNA. There-
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Figure 1. RAP1 affects TRF2 properties towards linear and branched DNA. (A) A total of 5 nM of telomeric Holliday Junction (tHJ) labelled on strand
indicated at the top was incubated with 200 nM of TRF2 with and without increasing amount of RAP1 prior to cleavage with GEN1[1–527]. tHJ is a
mobile Holliday junction that contains 4 (TTAGGG) repeats (one in each arm of the junction). The thick line of each representation corresponds to the
labelled arms. Concentrations of RAP1 used were 100, 200, 400, 1000, 1500 nM (experiment on the left) or at 1500 nM for the other three experiments.
(B) 5 nM of tHJ labelled on strand 4 was incubated with increasing amounts of TRF2L prior to cleavage with either Endonuclease I, CCE1 or RusA.
Concentrations of TRF2L used were 10, 20, 50, 100, 200, 500, 1000 nM. In lanes 3, 12 and 21 the junction is incubated with 200 nM of TRF2 prior to
cleavage. In lanes 29 and 30 the junction is incubated with 1000 nM of TRF2 and TRF2L. (C) 5 nM of tHJ labelled on strand 4 was incubated with 200
nM of TRF2L with and without increasing amount of RAP1 prior to cleavage with either Endonuclease I, CCE1 or RusA. Concentrations of RAP1
used were 100, 200, 400, 1000, 1500 nM. In lanes 3, 12 and 21 the junction is incubated with 1500 nM of RAP1 prior to cleavage. In lanes 4, 13 and 22 the
junction is incubated with 200 nM of TRF2 prior to cleavage. In lanes 29, 30 and 31 the junction is incubated with 1500 nM of RAP1, 200 nM of TRF2
and 200 nM of TRF2L. (D) Two-dimensional probability maps calculated from AFM experiments showing the binding of TRF2 (10 nM of dimers) on a
650 bp telomeric DNA (10 nM) either alone (top panel) or in the presence of 40 nM (monomer) of either full-length RAP1 (middle panel) or RAP1-RCT
(bottom panel). Yellow dotted lines show the contour length of unbound DNA. Green and red dotted lines show the contour length and volume of the
main TRF2–DNA complex respectively. Colour scale of the probability on the right of the maps.
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fore, these properties of RAP1 necessarily involve addi-
tional regions than the described TRF2 high affinity bind-
ing area.
Interaction of RAP1 with TRF2 is associated to conforma-
tional adjustment
The effect of RAP1 on TRF2 properties toward DNA
raised questions on the structure of the TRF2/RAP1 com-
plex. In particular, we wanted to investigate whether the
modified behaviour of TRF2 in the presence of RAP1 re-
sulted from a conformational adjustment.
TRF2 and RAP1 are each made of globular domains
linked by long unstructured regions, including residues 1–
42 and 245–445 in the case of TRF2 that correspond to al-
most 50% of the sequence, and residues 1–20, 245–275 and
316–445 in the case of RAP1 that correspond to 45% of the
sequence. This suggests a particularly high flexibility of the
individualmolecules as well as of theRAP1/TRF2 complex
(Figure 2A), which is not compatible with X-ray crystal-
lography or electron microscopy approaches. Moreover, the
size of the complex (around 200 kDa) impedes a straightfor-
ward nuclear magnetic resonance study. On the opposite,
Small Angle X-ray Scattering (SAXS) analysis is particu-
larly appropriate to gain information about the structura-
tion and the average conformation of flexible proteins and
their assembly in solution (50). For each of the isolated full
length TRF2, full length RAP1 and RAP1/TRF2 complex,
RAP1-RCT construct containing residues 270–399 (blue ar-
row on Figure 2A), and RAP1-RCT/TRF2 complex, and
after careful control of the high purity level (>95%) and
structural integrity of our tag-free samples (Supplementary
Figure S4), we collected SAXS curves on SWING beamline
at SOLEIL synchrotron, using the online HPLC to avoid
any sample aggregation (39). The experimental molecular
weight derived from the SAXS curves revealed that TRF2
is a dimer, that RAP1 is a partially unstructured monomer
and that RAP1/TRF2 contains one TRF2 dimer and two
RAP1 monomers (Figure 2B). The p(R) functions and nor-
malized Kratky plots (51) show that proteins alone or in
complex behave as elongated molecules and adopt either
partially unfolded (in the case of RAP1) or pearl-necklace-
like conformation (Supplementary Figure S5). The high
flexibility was not compatible with calculation of reliable 3D
models and we chose to calculate ab initio envelopes defined
as chain-like ensembles of dummy residues (see Supplemen-
tary Data). TRF2 dimer is highly extended with a high de-
gree of flexibility and a distance between the Myb DNA-
binding domains of each monomer that can reach 230 A˚
(Figure 2C). TRF2, TRF2/RAP1 and TRF2/RAP1-RCT
complexes all display a pseudo two-fold symmetry although
no symmetry constraint was used during calculation pro-
cess (Figure 2E and SupplementaryFigure S5G). In the case
of the short constructRAP1-RCT, the complex formedwith
TRF2 does not involve particular conformational adjust-
ment (Supplementary Figure S6A). On the contrary, the su-
perimposition of TRF2 and RAP1/TRF2 envelopes shows
a spreading for the complex compared to TRF2 alone, in
agreement with the increased value of Dmax between the
two p(R) functions (Supplementary Figure S6B). In addi-
tion, the shape of RAP1/TRF2 envelope is not compatible
with a complete superimposition with TRF2 envelope and
two RAP1 envelopes (Supplementary Figure S6C and D).
Therefore, the formation of TRF2/RAP1 complex involves
a major conformational adjustment of both proteins.
In order to further characterize and quantify
TRF2/RAP1 mode of assembly, we measured the in-
teraction between full-length RAP1 and TRF2 by ITC.
We chose this method because it is the only one able to
provide affinity constant and thermodynamic parame-
ters of the interaction between unlabelled molecules in
solution. As compared to previous studies, we used high
protein concentration, and low temperature, which favour
low affinity interaction (37, Supplementary Figure S7A).
In these particular conditions, we were able to observe
a reproducible biphasic isotherm. The non-linear least
squares fit of the data to a two-independent sites binding
model reveals a dissociation constant of less than 1 nM
for the high affinity signal, and a dissociation constant of
0.5 M for the lower affinity signal (Figure 2F). The high
affinity signal observed in the biphasic curve of the full-
length proteins is equivalent to the one measured between
RAP1-RCT and TRF2 (Figure 2G). The thermodynamic
parameters demonstrate that the high-affinity transition
corresponds to the known interaction between RAP1-RCT
and TRF2-RBM (Figure 2H, 28). The presence of a second
signal also suggests that the interaction between RAP1 and
TRF2 full length involves additional regions from both
partners than the previously described RAP1-RCT and
TRF2-RBM domains (28).
Complete interaction of RAP1 with TRF2 extends from
BRCT to C-terminal domain
Previous structural studies have shown that TRF2 dimer-
ization domain (TRFH) specifically interacts with pro-
teins containing the consensus sequence YxLxP or YRL
(15,17). This motif belongs to numerous TRF2 part-
ners among which the protein Apollo. Indeed a pep-
tide containing the consensus sequence, Apollo-YLP
(494ATEFRGLALKYLLTPVNF511), interacts with the
TRFH domain with an affinity of 120 nM (15), or 59 nM
in our hands (Supplementary Figure S7B). This motif is
present in RAP1 sequence at position 99YRLGP103, located
at the C-terminus of the BRCT domain (Figure 2A). The
corresponding peptide 89ENRERLELEAYRLGPASA106
(RAP1-YLP) interacts with TRFHwith a dissociation con-
stant of 13.0 M (Supplementary Figure S7C). In order to
delineate the structural determinants of this interaction we
solved the crystal structure of the RAP1-YLP/TRFH com-
plex at 2.4A˚ resolution (Figure 3A and B). The superimpo-
sition of our structure with this of TRFH in complex with
the Apollo-YLP peptide (PDB entry: 3BUA, 15) shows that
the structures are similar, although the N-terminal part of
Apollo-YLP and RAP1-YLP peptides are oriented in op-
posite directions (Figure 3C). In the case of the Apollo pep-
tide, substitution of Tyr, Leu or Pro into Ala affects the in-
teraction with the TRFH domain, although the effect was
not equivalent for each position (15).Wemutated the region
99YRLGP103 into 99ARAGA103 inRAP1 full length and, af-
ter checking the structural integrity of this RAP1-ARAGA
mutant by circular dichroism (Supplementary Figure S4C–
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Figure 2. Formation of TRF2 complex with RAP1 is associated to conformational adjustment and biphasic signal of interaction. (A) Domains organi-
zation of RAP1 and TRF2. The blue arrow shows the limit of RAP1-RCT construct. (B) Table of theoretical molecular weight (MWth), giration radius
(Rg), maximal distances (Dmax) and experimental molecular weight (MWexp) from Guinier calculation performed with each corresponding SAXS curve.
(C–E) Ab initio averaged envelopes of TRF2 (C), RAP1 (D) and TRF2/RAP1 (E) with superimposed globular domains as references. (F and G) ITC
characterization of the interaction between TRF2 and RAP1 (F) or RAP1-RCT (G). (H) thermodynamic parameter associated to the ITC experiment
performed for TRF2/RAP1 (F), with parameters associated to the first (a) and second (b) transition and for TRF2/RAP1-RCT.
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Figure 3. Complete interaction of RAP1 with TRF2 involves YXLXP motif and TRF2 dimerization domain. (A) Superimposition of the four TRFH
monomers observed in the crystal asymmetric unit (from pale to dark yellow) and of the four corresponding RAP1-YLP peptides (from pale to dark
cyan). (B) 2Fo-Fc electron density map at 1sigma level (blue mesh) around one RAP1 peptide represented in ball and stick cyan, with motif Tyr-Leu-Pro in
magenta. (C) Superimposition of TRFH (yellow) in complex with Apollo-YLP (dark purple) or RAP1-YLP peptide (cyan). The region of TRFH involved
in the interaction with Apollo-YLP is shown in violet, and with RAP1-YLP in light cyan. The rms deviation calculated on C-alpha of each of the four
TRFH monomer/RAP1-YLP and of TRFH monomer/Apollo-YLP is between 0.54 and 0.88 A˚. (D) ITC characterization of the interaction between
TRF2 with RAP1-ARAGA.
E), we measured its interaction with TRF2. The high affin-
ity ITC transition is maintained with the same dissociation
constant than for wild-type RAP1, but the low affinity sig-
nal becomes not significant (Figure 3D), as in the case of
RAP1-RCT (Figure 2G). Altogether, our data indicate that
the sequence YRLGP99–103 from RAP1 interacts with the
TRFH domain, is essential for the secondary interaction to
occur with TRF2, and is necessary for a complete interac-
tion of RAP1 with TRF2, although the residual secondary
signal suggests that additional regions may participate.
RAP1 stretches along TRF2 dimerization domain
In order to probe the protein surfaces involved
in TRF2/RAP1 assembly, we performed protein
footprinting using in vitro lysine acetylation by N-
hydroxysulfosuccinimide acetate. This compound can
acetylate lysines that are solvent-accessible but neither
those buried in the structure nor those protected by
interactions with another molecule. Through analysis of
acetylation profiles using mass spectrometry, it is thus
possible to determine which lysines are protected/buried in
a protein. TRF2 monomer and RAP1 contain respectively
44 and 25 lysines among which we observed acetylation for
24 lysines from TRF2 and 14 from RAP1 (Supplementary
Figures S8 and 9). We compared the lysine acetylation
profiles of TRF2, RAP1 and RAP1-ARAGA alone,
from these of TRF2/RAP1 and TRF2/RAP1-ARAGA
complexes. The comparison of lysine acetylation profiles
between protein alone or in complex highlights various
lysine populations that are: (i) acetylated in all conditions,
indicating constantly accessible regions that are therefore
not involved in the interactions; (ii) acetylated in the
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proteins alone and not in the complex with RAP1 wild type
or with RAP1-ARAGA, indicating regions that participate
in the interaction; or (iii) acetylated in the proteins alone
and in the complex with RAP1-ARAGA but not with
wild-type RAP1, showing that the mutation ARAGA
affects the interaction in this region; (iv) not acetylated in
the proteins alone and acetylated in either both complexes
or in TRF2/RAP1 complex only, pointing regions that
become accessible upon complex formation, probably due
to an opening of the corresponding region (Supplementary
Data, Supplementary Figures S8 and 9). Taken together,
the modifications in acetylation profiles allowed us to map
the region of TRFH domain and RAP1 N-terminal region
involved or not in TRF2/RAP1 complex and affected
or not by the ARAGA mutation (Figure 4A and B, and
Supplementary Figure S10).
Altogether, our results not only confirm the interaction
of the N-terminal moiety of RAP1 with TRFH, but also
enable us to draw an interaction path along TRFH and
RAP1-Nter, and to propose an interaction scheme (Figure
4C, and Supplementary video). When the TRFH dimer is
oriented with the inner side on top, RAP1 interaction path
goes through the area facing us of the right monomer, the
symmetrical surface still being accessible for the binding
of a second RAP1 molecule without any steric hindrance
and ends at both the N- and C-terminal ends at the bot-
tom of the TRFH domain (Figure 4C, left). Interestingly,
the location of theYxLxP peptide at one extremity ofRAP1
BRCT domain implies that RAP1/TRF2 assembly induces
a dimerization of the BRCT domain (Figure 4C, right).
Therefore, RAP1 complete interaction with TRF2 anchors
both at the C-terminal domain and at the YxLxP sequence
from the BRCT domain, and involves large additional re-
gions from both proteins. Conservation analysis of TRF2
and RAP1 among vertebrates shows that the region of the
TRFH domain from TRF2 that binds the motif YxLxP is
highly conserved in agreement with its known crucial impli-
cation in TRF2 function (Figure 4D, right). In the case of
RAP1, theYRLmotif (17) is 100% conserved among verte-
brates, and the surface from theN-terminal moiety involved
in the interaction with TRFH domain from TRF2 is highly
conserved, in agreement with an important function among
vertebrates (Figure 4D, left).
Comparison of RAP1 and RAP1-ARAGA effect on TRF2
protein binding properties
The partial overlap between RAP1-YLP and Apollo-YLP
binding sites on the TRFH domain raises the question of a
possible competition between both proteins for TRF2 bind-
ing. The strong difference in affinities for TRFH domain
exhibited by RAP1-YLP and Apollo-YLP (13 M ver-
sus 59 nM respectively) suggests that Apollo-YLP should
be able to interact with TRF2 in the presence of RAP1.
On the other hand, the high-affinity site provided by the
RAP1-RCT/ TRF2-RBM anchor (1 nM) brings the two
molecules together thus increasing local concentration of
the RAP-YLP. To choose between these two hypotheses,
we measured both interactions of the Apollo-YLP peptide
on a pre-formed TRF2–RAP1 complex and of RAP1 on a
pre-formed TRF2/Apollo-YLP peptide complex (Supple-
mentary Figure S7C–E). In the first case, we observed a
binding of the Apollo-YLP peptide with an affinity of 47
nM, similar to this of 46 nM obtained in the absence of
RAP1. In the case of pre-formed TRF2/Apollo-YLP com-
plex, we still observed a biphasic isotherm, although the
low affinity signal was too low to be quantified. This sug-
gests that the formation of RAP1/TRF2 complex does not
affect TRF2 binding properties toward Apollo protein, in
agreement with the in vivo described capacity of Apollo to
interact with TRF2 in the presence of RAP1 (13).
In order to further verify how RAP1–YLP interac-
tion may affect the binding properties of TRF2, we de-
signed a streptavidin-DNA pull down experiment, us-
ing a biotinylated (T2AG3)2 oligo-nucleotide immobilized
on a streptavidin column. After saturation of the im-
mobilized oligonucleotide with TRF2, TRF2/RAP1 or
TRF2/RAP1-ARAGA, we injected HeLa cells nuclear ex-
tract, washed, eluted bound proteins by increasing ionic
strength and compared both chromatography elution and
SDS-PAGE profiles. We first observe that the chromatog-
raphy elution profiles are different in the case of TRF2,
TRF2/RAP1 and TRF2/RAP1-ARAGA (Supplementary
Figure S12). We performed our comparison on the region
of the gel corresponding to molecular weight higher than
this of TRF2 orRAP1 in order to avoid contamination with
degradation products of TRF2, RAP1 or RAP1-ARAGA.
We first observed that a large number of proteins are re-
tained by TRF2, TRF2/RAP1 or TRF2/RAP1-ARAGA
(lanes 5, 8 and 11 respectively in Figure 5A). Our compar-
ison focuses on the presence or absence of specific bands,
and not of their intensity, which would not be significant
enough. We observed that the presence of RAP1 or RAP1-
ARAGA is associatedwith supplementary bands compared
to TRF2 alone, which agrees with TeloPIN. As RAP1
does not directly interact with DNA, we didn’t compare
the binding properties of RAP1 to these of RAP1/TRF2.
On the contrary, comparison of RAP1/TRF2 and RAP1-
ARAGA/TRF2 provides pieces of information on the ef-
fect of RAP1–YLP interaction with TRF2. Interestingly,
we observed that the SDS-PAGE patterns are different
between RAP1/TRF2 and RAP1-ARAGA/TRF2 (lanes
8 and 11 in Figure 5B). Therefore, the binding proper-
ties of TRF2/RAP1 or TRF2/RAP1-ARAGA, loaded on
(T2AG3)2 oligonucleotide, are different. We conclude that
themutation of theYxLxPmotif associated to the complete
interaction of RAP1 with TRF2 dimerization domain di-
rectly affects the binding properties of the assembly formed
with TRF2.
Effect of RAP1[1–208] on TRF2 HJ protection
In the initial steps of this study, we observed that RAP1 af-
fect the ability of TRF2 to protect HJ from resolvase ac-
tivity even after deletion of RAP1 binding motif of TRF2
(Figure 1A–C). Acetylation profile shows that both RAP1-
wt andRAP1-ARAGAprotects from acetylation lysines lo-
cated near the N-terminal region of TRF2: Lys58, Lys93,
Lys242 and Lys245. On the contrary, RAP1-wt protects
Lys184 and Lys190 but RAP1-ARAGA does not (Figure
4A and C, left). It has been previously observed that the HJ
protection involves the N-terminal region of TRF2 (25), lo-
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Figure 4. Complete interaction of RAP1 with TRF2 involves large area from RAP1 N-terminal moiety and TRF2 dimerization domain. (A and B)
Acetylation profile of lysine residues in TRF2, RAP1 or RAP1-ARAGA alone, compared to TRF2/RAP1 or TRF2/RAP1-ARAGA. Lysine residues are
represented in small sphere and coloured differently if they are protected (blue, or light blue if the precise acetylation position was not determined), more
accessible (red), or not affected (black) in both TRF2/RAP1 and TRF2/RAP1-ARAGA complex, or protected (green) or more accessible (orange) only
in TRF2/RAP1 complex. Residues Y-L-P are shown as purple spheres. The inserted tables show the lysine number in the sequence, highlighted in blue
in RAP1 globular domain, in yellow in TRF2 globular domain. The acetylation profile follows the same colour code as in the structure representation.
(A) TRFH/RAP1-YLP peptide crystal structure; (B) Juxtaposition of RAP1[1–121] 3D model calculated with Modeller (41), and RAP1-Myb nuclear
magnetic resonance structure (PDB entry: 1FEX). (C) Positioning of RAP1 BRCT and Myb domains on TRFH surface based on combination of the
crystal structure and footprinting experiments, showing on the right side the induced dimerization of BRCT domain (colour code identical than in Figure
3). (D) Surface representation of RAP1[1–208] coloured upon the conservation score of CONSURF software (48) with the trace of the TRFH domain
in black shadow (left); Surface representation of TRFH domain of TRF2 coloured upon the conservation score of CONSURF software (48) with the
RAP1-YLP peptide in black (right). All structure representations were drawn with software Pymol (47).
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cated close to the region protected by both RAP1-wt and
RAP1-ARAGA, but on the opposite side from the region
that binds RAP1 YxLxP motif or from the region pro-
tected by RAP1-wt only. Therefore, we expect that a con-
struct of RAP1 lacking the high-affinity C-terminal TRF2
binding site should have similar effect on HJ protection by
TRF2 than this observed with RAP1 on TRF2 L, and
thatRAP1 orRAP1-ARAGAshould affect in the sameway
HJ protection by TRF2.
We tested the effect of RAP1-ARAGA and of RAP1[1–
208] on HJ protection by TRF2. We observed that RAP1-
ARAGA affects TRF2 HJ protection in a similar manner
than RAP1-wt. The effect of RAP1[1–208] on TRF2 HJ
protection is similar to this observed with RAP1 full length
on TRF2L mutant, a higher quantity of RAP1[1–208] is
necessary (Figure 5A) in the same way than a higher quan-
tity of RAP1 was necessary with TRF2L (Figure 1A,B
and C). Therefore, the interaction of RAP1[1–208] with a
region of TRF2 located at the bottom of the TRFHdomain
near the N-terminal region directly affects the property of
TRF2 to protect HJ from resolvase. We conclude that this
particular region is involved inHJ protection byTRF2 (Fig-
ure 4C).
DISCUSSION
Our comprehensive study of RAP1, TRF2 and the effect
of RAP1/TRF2 complex formation on their conformation
and interaction properties reveal new elements that strongly
deepen our knowledge of these two proteins and their inter-
relation. First of all, it is essential to remind how experi-
mental conditions and sample preparation may affect the
results. Although analyses of crystal structures show little
effect of the presence of His-tag (52), it has been shown that
His-tag can affect protein function and interaction prop-
erties (53,54). We therefore chose to exclusively work with
tag-free constructs of our proteins. We first observed that
RAP1 affects both the ability of TRF2 to form condensed
multimeric complexes with DNA and to protect Holliday
junction from resolvases (Figure 1), that the formation of
RAP1/TRF2 assembly is more complex than the known
RAP1-RCT/TRF2-RBM interaction (15), and that the as-
sembled molecules form a distinct entity. The combination
of SAXS and ITC analysis confirms that the formation
of RAP1/TRF2 complex involves a profound conforma-
tional adjustment (SAXS), associated with a two-transition
mode of interaction (ITC) (Figure 2). Moreover, the iso-
lated RAP1-RCT domain is not sufficient to induce a con-
formational adjustment, or a secondary ITC signal (Figure
2, Supplementary Figure S5G). A YXLXP motif (or YRL
motif), specific for the interaction with the TRF2 dimeriza-
tion domain, TRFH (15,17), is located at the C-terminus of
the BRCT domain of RAP1 at position 99–103. The crys-
tal structure of TRFH in complex with a peptide of RAP1
containing the YXLXP motif show that the molecular de-
terminants of the interaction involve theYXLXPmotif and
is similar to that previously described between TRFH and
Apollo-YLP peptide (Figure 3A–C, 15).Moreover, the sim-
ilar ITC interaction profiles between RAP1-ARAGA and
TRF2 (Figure 3C) and between RAP1 and the pre-formed
TRF2/Apollo-YLP complex (Supplementary Figure S6F)
show that the Apollo-YLP peptide compete with RAP1 for
binding on TRF2 TRFH domain. This competition is cen-
tred on the YXLXP site, although it is not documented
whether additional regions of full length Apollo might in-
teract with full length TRF2. The residual secondary sig-
nal in both cases also suggests that additional regions of
RAP1 are involved in the secondary binding site (Figure
3C and Supplementary Figure S6F). Protein footprinting
experiments allowed us to complete the RAP1/TRF2 inter-
action scheme and to model the assembly formed by RAP1
N-terminus region, comprising residues 1–211, and TRFH.
In this model, the N-terminus moiety of RAP1 follows one
face of the TRFH domain, interacts through YXLXP se-
quence in the inner part of the TRFH, and ends at the exter-
nal side of the domain (Figure 4C, left). Looking from the
top of the TRFH domain, we observe that this interaction
of the N-terminal region of RAP1 induces an unexpected
dimerization of the BRCT domain (Figure 4C, right). The
high conservation among vertebrates of the knownYXLXP
binding site of TRF2, of theYRLXPmotif of RAP1 and of
the surface of RAP1 involved in the secondary interaction
also reveals that this secondary interaction ofRAP1 and the
capacity of TRF2 to interact withYRLXPmotif containing
proteins are of equal importance.
The similar ITC interaction profiles between TRF2 and
Apollo-YLP and between the preformed TRF2/RAP1
complex and Apollo-YLP also suggests that RAP1 inter-
action may probably not hinder Apollo interaction (Sup-
plementary Figure S7C and D). Similar analysis could
apply to SLX4, which contains a TRFH binding mo-
tif (1014RGLEVHRLAPW1028), is characterized by a dis-
sociation constant of 750 nM with TRF2, and adopts
the same conformation than Apollo-YLP peptide in com-
plex with TRFH (PDB entry: 4M7C, 16). In TRF1
dimerization domain, the region equivalent to this of
TRF2 specifically interacts with the TIN2 protein. A
TIN2 peptide 248THPEPLAGRHFNLAPLGR265, specific
for TRF1 dimerization domain, interacts in vitro with
TRF2 TRFH with a dissociation constant of 6 M (15),
in the same order of magnitude than this of RAP1-YLP
peptide on TRF2 (13 M). The variable affinity measured
for the YXLXP-containing peptides suggests that RAP1
secondary interaction might (i) impede inappropriate bind-
ing on the TRFH of TRF2 in case of unspecific binding
to TRF2 TRFH of FxLxP containing proteins like TIN2
which are specific for TRF1 TRFH; (ii) vary depending
on the chemical environment. In this way, our streptavidin-
DNA pull down reveals that, when bound to a (T2AG3)2
oligonucleotide, RAP1/TRF2 or RAP1-ARAGA/TRF2
do not retain the same proteins from a HeLa nuclear ex-
tract. Therefore, the capacity ofRAP1 to formor not a com-
plete interaction with TRF2 through the YXLXP motif is
associated with different binding properties (Figure 5A).
In addition to this possible regulatory function, we have
seen that RAP1 does not modify TRF2 property to con-
dense DNA (Figure 1), but it does affect the oligomer-
ization level that we observed in AFM experiments. This
must be a consequence of the complete RAP1 interaction
since RAP1-RCT alone is not able to do so. The mech-
anism behind could involve steric hindrance or hiding of
an oligomerization-prone region of TRF2, located at or
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Figure 5. Interaction of RAP1 with TRF2 is associated to different binding properties. (A) Left panel, SDS-PAGE analysis of a typical streptavidin-DNA
pulldown experiment (Coomassie blue stained). Lanes contain: (1) input nuclear extract, (2) molecular weight marker (Weights from top to bottom: 250,
150, 100, 80, 60 kDa); (3) input purified TRF2, (4) nuclear extract flow through, (5) elution of TRF2-bound proteins; (6) input purified TRF2/RAP1
complex, (7) nuclear extract flow through, (8) elution of TRF2/RAP1-bound proteins; (9) input purified TRF2/RAP1-ARAGA complex, (10) nuclear
extract flow through, (11) elution of TRF2/RAP1-ARAGA-bound proteins; (12) nuclear extract flow through in absence of telomeric proteins, (13) elution
of DNA-bound proteins (control). Right panel, enlarged view of lanes 5, 8 and 11 of the SDS-PAGE. (B) 5 nM of tHJ labelled on strand 4 was incubated
with 200 nM of TRF2 with and without increasing amount of RAP1-ARAGA or RAP1[1–208] prior to cleavage with CCE1. Concentrations of RAP1-
ARAGA used were 200, 400, 1000, 1500, 3000 nM (lanes 8–12 and 3000 nM in lanes 4 and 20. Concentrations of RAP1[1–208] used were 100, 200, 400,
1000, 1500 nM (lanes 13–17), and 1500 nM in lanes 5 and 21. Concentration of RAP1-wt in lanes 3, 7 and 19 is 1500 nM. In lanes 3, 12 and 21 the junction
is incubated with 1500 nM of RAP1 prior to cleavage.
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Figure 6. Model of binding properties of TRF2/RAP1 assembly. Proposed model of the assembly of TRF2/RAP1 and the effect of its malleability on
its binding properties. The presence of RAP1 (cyan) prevents the binding of non-specific proteins like FLP containing proteins (orange) in the TBM area
of TRF2 (yellow), but does not prevent the binding of high-affinity YLP containing proteins (purple). In the absence of YLP containing proteins, RAP1
complete interaction induces the formation of BRCT dimer (blue circle) that could recruit new phosphorylated partners (green).
close to the TRFH domain. At last, RAP1 affects the basic
domain-dependent ability of TRF2 to protectHJ against re-
solvases. Although the precise mechanism remains to be de-
termined, our data show that the interaction of RAP1 with
the region of TRF2 located close to the N-terminus of the
TRFH domain is part of the mechanism behind the alter-
ation in the protection of HJ against resolvases (Figure 5B).
Based on our results, we propose an overall scheme of
the formation of the RAP1/TRF2 complex and the pos-
sible effect on their binding properties (Figure 6). RAP1
alone is highly flexible and extended, according to the Dmax
and normalized Kratky plot for the protein in solution. In
the absence of RAP1, TRF2 interacts with multiple part-
ners, with no site discrimination in the case of TIN2 (Fig-
ure 6, left). RAP1 conformation is clearly stabilized upon
RAP1/TRF2 complex assembly, as shown by the normal-
ized Kratky plots (Supplementary Figure S5E). The com-
plex could adopt alternative open or closed conformation
depending on the presence or absence of TRFH high-
affinity TBM-containing protein partners (such as Apollo
or SLX4) that compete with RAP1 N-terminal region, or
depending on the chemical environment that may favour or
not secondary interaction (Figure 6, right). RAP1/TRF2
closed conformation inhibits additional illicit interaction
with TRFH (such as the one with TIN2), induces RAP1
BRCT domain dimerization (Figure 4C), and forms a new
entity thatmay interact with other specific telomeric or non-
telomeric partners, whereas RAP1/TRF2 open conforma-
tion has different binding properties (Figure 6). Of note,
TRF2 alone, RAP1 alone and closed RAP1/TRF2 models
are in agreement with the combination of our results. The
open form model of RAP1/TRF2 complex is proposed to
account for the results of ITC and streptavidin-DNA pull
down experiments performed with RAP1-ARAGA as com-
pared to RAP1.
Our comprehensive study shows that RAP1 affects TRF2
conformation and function and that TRF2 also affects
RAP1 conformation. The induced dimerization of RAP1
BRCT domain upon full interaction with TRF2 is of par-
ticular interest (Figure 4C, right). The lysine acetylation
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profile of RAP1-ARAGA in the footprinting experiments
shows that mutation of the YxLxP motif affects RAP1 in-
teraction with TRFH, and particularly the induced dimer-
ization of the BRCT domain. In addition, the streptavidin-
DNA pull down shows that the capacity of RAP1 to form
a complete interaction with TRF2 or not is associated with
different binding properties. This provides both a clue about
the functional role of RAP1 BRCT domain, and for the
first time a possible explanation for the high conservation
of this domain among Rap1 proteins from yeast to hu-
man. Indeed, BRCT domains are found in a wide array of
prokaryotic and eukaryotic proteins. In human, at least 23
genes coding for proteins with BRCT domains have been
listed, most of them implicated in DNA damage response.
The induced dimerization mimics a BRCT tandem, known
for its propensity to interact with phosphorylated proteins
(55). The induced dimerization of RAP1 BRCT upon in-
teraction with TRF2 suggests that RAP1 functions could
be quite different whether RAP1 co-localizes with TRF2 or
not. A recent study using a separation-of-function mutant
of TRF2 has highlighted that RAP1 is involved in TRF2-
mediated anti-NHEJ function as a complementary pathway
(Benarroch-Popivker et al., in press). The precise role of the
BRCT domain in this function of RAP1 remains to be ad-
dressed.
Altogether, our data indicate that formation of the
RAP1/TRF2 complex needs the presence of several do-
mains of the proteins. Importantly, we show that the
RAP1/TRF2 complex forms a structural entity with dif-
ferent competences than individual RAP1 and TRF2. We
have shown that the available accessible surface of TRF2
or RAP1/TRF2 determines binding preferences for other
partners of TRF2. Determining which proteins are more
specific for TRF2 or for RAP1/TRF2 should provide a
key to the regulation of TRF2 and RAP1 functions. In
a general manner, one should consider RAP1, TRF2 and
RAP1/TRF2 as three distinct, although related, entities.
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